These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14686224)

  • 1. Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.
    Gandhi PJ; Menezes PA; Vu HT; Rivera AL; Ramaswamy K
    Am J Health Syst Pharm; 2003 Dec; 60(23):2479-83. PubMed ID: 14686224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Zeuli JD; Wilson JW; Estes LL
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1121-7. PubMed ID: 23229485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
    Tilton JJ; Sadr R; Groo VL
    J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole-induced torsade de pointes.
    Tholakanahalli VN; Potti A; Hanley JF; Merliss AD
    Ann Pharmacother; 2001 Apr; 35(4):432-4. PubMed ID: 11302406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
    Frothingham R
    Pharmacotherapy; 2001 Dec; 21(12):1468-72. PubMed ID: 11765299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
    Tatetsu H; Asou N; Nakamura M; Hanaoka N; Matsuno F; Horikawa K; Mitsuya H
    Am J Hematol; 2006 May; 81(5):366-9. PubMed ID: 16628725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of three fluoroquinolones on QT analysis after standard treatment courses.
    Tsikouris JP; Peeters MJ; Cox CD; Meyerrose GE; Seifert CF
    Ann Noninvasive Electrocardiol; 2006 Jan; 11(1):52-6. PubMed ID: 16472283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole.
    Esch JJ; Kantoch MJ
    Pediatr Cardiol; 2008 Jan; 29(1):210-3. PubMed ID: 17849073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
    Amankwa K; Krishnan SC; Tisdale JE
    Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
    Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA
    Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin-induced acquired long QT syndrome.
    Prabhakar M; Krahn AD
    Heart Rhythm; 2004 Nov; 1(5):624-6. PubMed ID: 15851230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis.
    McMahon JH; Grayson ML
    Am J Health Syst Pharm; 2008 Apr; 65(7):619-23. PubMed ID: 18359968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.
    Dorsey ST; Biblo LA
    Am J Emerg Med; 2000 Mar; 18(2):227-9. PubMed ID: 10750939
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.
    Poluzzi E; Raschi E; Motola D; Moretti U; De Ponti F
    Drug Saf; 2010 Apr; 33(4):303-14. PubMed ID: 20297862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsades de pointes associated with fluoroquinolones.
    Owens RC; Ambrose PG
    Pharmacotherapy; 2002 May; 22(5):663-8; discussion 668-72. PubMed ID: 12013370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.